BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 16545138)

  • 1. CD40L induces multidrug resistance to apoptosis in breast carcinoma and lymphoma cells through caspase independent and dependent pathways.
    Voorzanger-Rousselot N; Alberti L; Blay JY
    BMC Cancer; 2006 Mar; 6():75. PubMed ID: 16545138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance to cytotoxic chemotherapy induced by CD40 ligand in lymphoma cells.
    Voorzanger-Rousselot N; Favrot M; Blay JY
    Blood; 1998 Nov; 92(9):3381-7. PubMed ID: 9787177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coexpression of CD40 and CD40L on B lymphoma and carcinoma cells: an autocrine anti-apoptotic role.
    Voorzanger-Rousselot N; Blay JY
    Leuk Lymphoma; 2004 Jun; 45(6):1239-45. PubMed ID: 15360007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic cytotoxicity of Bcl-xL inhibitor, gossypol and chemotherapeutic agents in non-Hodgkin's lymphoma cells.
    Li ZM; Jiang WQ; Zhu ZY; Zhu XF; Zhou JM; Liu ZC; Yang DJ; Guang ZZ
    Cancer Biol Ther; 2008 Jan; 7(1):51-60. PubMed ID: 17938578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of heat shock protein 90 function by 17-allylamino-17-demethoxy-geldanamycin in Hodgkin's lymphoma cells down-regulates Akt kinase, dephosphorylates extracellular signal-regulated kinase, and induces cell cycle arrest and cell death.
    Georgakis GV; Li Y; Rassidakis GZ; Martinez-Valdez H; Medeiros LJ; Younes A
    Clin Cancer Res; 2006 Jan; 12(2):584-90. PubMed ID: 16428504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calpain inhibitor II induces caspase-dependent apoptosis in human acute lymphoblastic leukemia and non-Hodgkin's lymphoma cells as well as some solid tumor cells.
    Zhu DM; Uckun FM
    Clin Cancer Res; 2000 Jun; 6(6):2456-63. PubMed ID: 10873099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-tumoral effect of arsenic compound, sodium metaarsenite (KML001), in non-Hodgkin's lymphoma: an in vitro and in vivo study.
    Yoon JS; Hwang DW; Kim ES; Kim JS; Kim S; Chung HJ; Lee SK; Yi JH; Uhm J; Won YW; Park BB; Choi JH; Lee YY
    Invest New Drugs; 2016 Feb; 34(1):1-14. PubMed ID: 26581399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-CD20 antibody (IDEC-C2B8, rituximab) enhances efficacy of cytotoxic drugs on neoplastic lymphocytes in vitro: role of cytokines, complement, and caspases.
    Chow KU; Sommerlad WD; Boehrer S; Schneider B; Seipelt G; Rummel MJ; Hoelzer D; Mitrou PS; Weidmann E
    Haematologica; 2002 Jan; 87(1):33-43. PubMed ID: 11801463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceramide-induced apoptosis in fas-resistant Hodgkin's disease cell lines is caspase independent.
    Metkar SS; Anand M; Manna PP; Naresh KN; Nadkarni JJ
    Exp Cell Res; 2000 Feb; 255(1):18-29. PubMed ID: 10666330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD40 ligand stimulation inhibits the proliferation of mantle cell lymphoma lines.
    Jin Z; Teramoto N; Hayashi K; Liu YX; Jin G; Oka T; Takahashi K; Yoshino T; Akagi T
    Anticancer Res; 2004; 24(2B):691-7. PubMed ID: 15161013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol modifies the expression of apoptotic regulatory proteins and sensitizes non-Hodgkin's lymphoma and multiple myeloma cell lines to paclitaxel-induced apoptosis.
    Jazirehi AR; Bonavida B
    Mol Cancer Ther; 2004 Jan; 3(1):71-84. PubMed ID: 14749477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth-inhibitory effects of CD40 ligand (CD154) and its endogenous expression in human breast cancer.
    Tong AW; Papayoti MH; Netto G; Armstrong DT; Ordonez G; Lawson JM; Stone MJ
    Clin Cancer Res; 2001 Mar; 7(3):691-703. PubMed ID: 11297266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ionizing radiation but not anticancer drugs causes cell cycle arrest and failure to activate the mitochondrial death pathway in MCF-7 breast carcinoma cells.
    Jänicke RU; Engels IH; Dunkern T; Kaina B; Schulze-Osthoff K; Porter AG
    Oncogene; 2001 Aug; 20(36):5043-53. PubMed ID: 11526489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab enhances radiation-triggered apoptosis in non-Hodgkin's lymphoma cells via caspase-dependent and - independent mechanisms.
    Skvortsova I; Skvortsov S; Popper BA; Haidenberger A; Saurer M; Gunkel AR; Zwierzina H; Lukas P
    J Radiat Res; 2006 Jun; 47(2):183-96. PubMed ID: 16819145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticancer agents sensitize tumor cells to tumor necrosis factor-related apoptosis-inducing ligand-mediated caspase-8 activation and apoptosis.
    Lacour S; Hammann A; Wotawa A; Corcos L; Solary E; Dimanche-Boitrel MT
    Cancer Res; 2001 Feb; 61(4):1645-51. PubMed ID: 11245478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis induction in renal cell carcinoma by TRAIL and gamma-radiation is impaired by deficient caspase-9 cleavage.
    Ramp U; Caliskan E; Mahotka C; Krieg A; Heikaus S; Gabbert HE; Gerharz CD
    Br J Cancer; 2003 Jun; 88(11):1800-7. PubMed ID: 12771998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab (anti-CD20) selectively modifies Bcl-xL and apoptosis protease activating factor-1 (Apaf-1) expression and sensitizes human non-Hodgkin's lymphoma B cell lines to paclitaxel-induced apoptosis.
    Jazirehi AR; Gan XH; De Vos S; Emmanouilides C; Bonavida B
    Mol Cancer Ther; 2003 Nov; 2(11):1183-93. PubMed ID: 14617792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to CD95-mediated apoptosis through constitutive c-FLIP expression in a non-Hodgkin's lymphoma B cell line.
    Irisarri M; Plumas J; Bonnefoix T; Jacob MC; Roucard C; Pasquier MA; Sotto JJ; Lajmanovich A
    Leukemia; 2000 Dec; 14(12):2149-58. PubMed ID: 11187905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfection of caspase-3 in the caspase-3-deficient Hodgkin's disease cell line, KMH2, results in enhanced sensitivity to CD95-, TRAIL-, and ARA-C-induced apoptosis.
    Wrone-Smith T; Izban KF; Ergin M; Cosar EF; Hsi ED; Alkan S
    Exp Hematol; 2001 May; 29(5):572-81. PubMed ID: 11376869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PCI-24781 induces caspase and reactive oxygen species-dependent apoptosis through NF-kappaB mechanisms and is synergistic with bortezomib in lymphoma cells.
    Bhalla S; Balasubramanian S; David K; Sirisawad M; Buggy J; Mauro L; Prachand S; Miller R; Gordon LI; Evens AM
    Clin Cancer Res; 2009 May; 15(10):3354-65. PubMed ID: 19417023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.